These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 35367619)

  • 1. Single-center retrospective analysis of Pneumocystis jirovecii pneumonia in patients after deceased donor renal transplantation.
    Zou J; Wang T; Qiu T; Zhou J; Chen Z; Ma X; Jin Z; Xu Y; Zhang L
    Transpl Immunol; 2022 Jun; 72():101593. PubMed ID: 35367619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and diagnostic value of metagenomic next -generation sequencing in five cases of non-HIV related
    Niu J; Wang J; Jia P; Zhang M; Wei E
    Front Cell Infect Microbiol; 2023; 13():1132472. PubMed ID: 37009508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of metagenomic next-generation sequencing in the diagnosis and treatment guidance of Pneumocystis jirovecii pneumonia in renal transplant recipients.
    Zhang F; Chen J; Huang H; Deng X; Zhang W; Zeng M; Liu R; Dai L; Wan Q
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1933-1942. PubMed ID: 33880744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Metagenomic Next-Generation Sequencing to Diagnose Pneumocystis jirovecii Pneumonia in Kidney Transplantation Recipients.
    Xu J; Yu Y; Lv J; Yang S; Wu J; Chen J; Peng W
    Ann Transplant; 2021 Jun; 26():e931059. PubMed ID: 34099614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical descriptive analysis of severe
    Xie D; Xu W; You J; Yuan X; Li M; Bi X; Zhang K; Li H; Xian Y
    Bioengineered; 2021 Dec; 12(1):1264-1272. PubMed ID: 33896387
    [No Abstract]   [Full Text] [Related]  

  • 6. High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of c aspofungin combined with TMP/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia.
    Jin F; Liu XH; Chen WC; Fan ZL; Wang HL
    Int J Infect Dis; 2019 Nov; 88():141-148. PubMed ID: 31442630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence and mortality of Pneumocystis jirovecii pneumonia in anti-MDA5 antibody-positive dermatomyositis.
    Chen X; Shu X; He L; Yang H; Lu X; Wang G; Ge Y
    Rheumatology (Oxford); 2023 Oct; 62(10):3302-3309. PubMed ID: 36734589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors associated with Pneumocystis jirovecii pneumonia in non-HIV immunocompromised patients and co-pathogens analysis by metagenomic next-generation sequencing.
    Huang L; Xu S; Huang Z; Chen Y; Xu N; Xie B
    BMC Pulm Med; 2023 Feb; 23(1):72. PubMed ID: 36829171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VV-ECMO combined with prone position ventilation in the treatment of Pneumocystis jirovecii pneumonia: A case report.
    Jia L; Zhang Z; Bai Y; Du Q
    Medicine (Baltimore); 2022 Jan; 101(1):e28482. PubMed ID: 35029898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic value of metagenomic next-generation sequencing for identifying
    Zhao M; Yue R; Wu X; Gao Z; He M; Pan L
    Front Cell Infect Microbiol; 2022; 12():1026739. PubMed ID: 36389151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk factor analysis and treatment experience in pneumocystis jirovecii pneumonia after kidney transplantation.
    Yang P; Zhu X; Liang W; Cai R
    Mycoses; 2021 May; 64(5):495-502. PubMed ID: 33368732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of caspofungin and low-dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients.
    Tu GW; Ju MJ; Xu M; Rong RM; He YZ; Xue ZG; Zhu TY; Luo Z
    Nephrology (Carlton); 2013 Nov; 18(11):736-42. PubMed ID: 24571744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A regimen based on the combination of trimethoprim/sulfamethoxazole with caspofungin and corticosteroids as a first-line therapy for patients with severe non-HIV-related pneumocystis jirovecii pneumonia: a retrospective study in a tertiary hospital.
    Li H; Lu Y; Tian G; Wu Y; Chen T; Zhang J; Hu N; Wang X; Wang Y; Gao L; Yan J; Zhou L; Shi Q
    BMC Infect Dis; 2024 Jan; 24(1):152. PubMed ID: 38297200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Performance of BAL Metagenomic Next-Generation Sequence and Serum (1,3)-β-D-Glucan for Differential Diagnosis of
    Liu L; Yuan M; Shi Y; Su X
    Front Cell Infect Microbiol; 2021; 11():784236. PubMed ID: 35004353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metagenomic next-generation sequencing promotes diagnosis and treatment of Pneumocystis jirovecii pneumonia in non-HIV infected children: a retrospective study.
    Zhang Z; Liu T; Ming M; Shen M; Zhang Y; Chen H; Chen W; Tao J; Wang Y; Liu J; Zhou J; Lu G; Yan G
    BMC Pulm Med; 2024 Jul; 24(1):338. PubMed ID: 38997717
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Tiantian C; Jin Y; Jing Z; Jing F; Xiaoyan J
    J Int Med Res; 2022 Jun; 50(6):3000605221105358. PubMed ID: 35751409
    [No Abstract]   [Full Text] [Related]  

  • 17. Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
    Neofytos D; Hirzel C; Boely E; Lecompte T; Khanna N; Mueller NJ; Boggian K; Cusini A; Manuel O; van Delden C;
    Transpl Infect Dis; 2018 Dec; 20(6):e12984. PubMed ID: 30155950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Characteristics of
    Li T; Shi J; Xu F; Xu X
    Infect Drug Resist; 2020; 13():81-88. PubMed ID: 32021322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative serum (1,3) -β-D-glucan has a low power to exclude Pneumocystis jirovecii pneumonia (PJP) in HIV-uninfected patients with positive qPCR.
    Huang Y; Yi J; Song JJ; Du LJ; Li XM; Cheng LL; Yan SX; Li HL; Liu YM; Zhan HT; Dou YL; Li YZ
    Ann Clin Microbiol Antimicrob; 2023 Nov; 22(1):102. PubMed ID: 37986091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twice weekly prophylaxis with trimethoprim/sulfamethoxazole for
    Awad M; Sierra CM; Mesghali E; Bahjri K
    J Oncol Pharm Pract; 2021 Dec; 27(8):1936-1939. PubMed ID: 33307970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.